New quick MRI could slash prostate cancer scan costs by 30%
NCT ID NCT05046782
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study aimed to test an abbreviated MRI method (using restriction spectrum imaging plus T2-weighted images) for detecting prostate cancer, comparing it to the standard multiparametric MRI. The goal was to see if the faster, cheaper scan could find cancer just as well, while avoiding contrast dye and reducing scan time and cost. However, the study was withdrawn before any participants were enrolled, so no results were obtained.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
restriction spectrum imaging (RSI) MRI device
What this could lead to
If successful, this could provide a faster, cheaper, and safer MRI option for prostate cancer detection, reducing scan time and cost by up to 40%.
What could go wrong
The study was withdrawn before enrolling any participants, so no results are available. The approach may not prove as accurate as standard MRI in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.